Neil Thomas Blackburn

Title: Neil Thomas Blackburn: Innovator in Immunological Interventions

Introduction

Neil Thomas Blackburn is a notable inventor based in Newark, DE (US), recognized for his contributions to the field of immunology. With a total of 2 patents, Blackburn has made significant strides in developing synthetic and natural antigens aimed at treating inflammatory pathologies.

Latest Patents

His latest patents include "Synthetic polysaccharide antigens for immunological intervention in disease," which provides synthetic polysaccharide antigens (SPAs) with either anti-inflammatory or inflammatory immunomodulatory properties, depending on their structure. This patent outlines compositions that utilize these SPAs and methods for their application in preventing or treating diseases susceptible to inflammatory immunomodulators. Another significant patent is "Immunomodulatory polymeric antigens for treating inflammatory pathologies," which details both natural and synthetic immunomodulatory polymeric antigens, their compositions, and methods for their use in preventing or treating inflammatory conditions.

Career Highlights

Neil Thomas Blackburn is currently associated with Eli Lilly and Company, where he continues to innovate in the field of immunology. His work focuses on developing new therapeutic strategies to combat inflammatory diseases, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Blackburn has collaborated with esteemed colleagues, including Kathleen Ann Taylor and Larry C Blaszczak, contributing to a rich environment of innovation and research.

Conclusion

Neil Thomas Blackburn stands out as a significant figure in the realm of immunological inventions, with his patents paving the way for new treatments in inflammatory diseases. His work at Eli Lilly and Company exemplifies the impact of innovative thinking in healthcare.